1,8-Diazabicyclo(5.4.0)undec-7-ene → [4-(2,4-Dioxo(1,3-dihydroquinazolin-3-yl))phenyl]-n-[(5-chloro(2-thienyl))sulfonyl]carboxamide

HRID 38143

반응식

HRID 38143 반응식
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([NH:10][S:11]([C:14]2[S:15][C:16]([Cl:19])=[CH:17][CH:18]=2)(=[O:13])=[O:12])=[O:9])=[CH:4][CH:3]=1.[N:20]([C:23]1[CH:32]=[CH:31][CH:30]=[CH:29][C:24]=1[C:25](OC)=[O:26])=[C:21]=[O:22].C1CCN2C(=NCCC2)CC1>C1COCC1>[O:22]=[C:21]1[N:1]([C:2]2[CH:7]=[CH:6][C:5]([C:8]([NH:10][S:11]([C:14]3[S:15][C:16]([Cl:19])=[CH:17][CH:18]=3)(=[O:13])=[O:12])=[O:9])=[CH:4][CH:3]=2)[C:25](=[O:26])[C:24]2[C:23](=[CH:32][CH:31]=[CH:30][CH:29]=2)[NH:20]1

참가 물질

5

반응물 3

HCID 811841,8-Diazabicyclo(5.4.0)undec-7-eneHCID 519494Methyl 2-isocyanatobenzoateHCID 131724995HCID 131724995, 화합물

생성물 1

HCID 20800263[4-(2,4-Dioxo(1,3-dihydroquinazolin-3-yl))phenyl]-n-[(5-chloro(2-thienyl))sulfonyl]carboxamide수율 34%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

A 44 mg portion (0.14) of (4-aminophenyl)-N-[(5-chloro(2-thienyl))sulfonyl]carboxamide was combined with 25 mg (0.14 mmol) of methyl 2-isocyanatobenzoate in 500 uL of THF followed by the addition of 1 equivalent of TEA (24 μL) and 1 equivalent of DBU. After 18 h, the mixture was purified by RP-HPLC, to give 21 mg (34%) of the desired compound. ES-MS (M+H)+=462 (Cl).

후처리

  1. customthe mixture was purified by RP-HPLC

출처 및 근거

ORD 기록
ord-75f7eae99314419cb9893602e8a3a03e
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08524721B2

연결된 노트

불러오는 중…